Last reviewed · How we verify
NCT03656367: DAIRYMAT
Designing Biofunctional Dairy Foods: Matrix Structure of Dairy Products in Relation to Lipaemia
NA trial testing Cheddar cheese in Lipaemia in 25 participants. Completed in 21 March 2019.
21 March 2019
Quick facts
| Lead sponsor | Anne Birgitte Raben |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 25 |
| Start date | 10 September 2018 |
| Primary completion | 21 March 2019 |
| Estimated completion | 21 March 2019 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Cheddar cheese
- Blended and homogenized cheddar cheese
- An analog milk
- An analog cheese
Conditions studied
- Lipaemia — all drugs for Lipaemia →
Sponsor
Anne Birgitte Raben
Who can join
Adults 18 to 40, male only, with Lipaemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall aim of this study is to investigate how dairy products with different structures and textures affect lipid absorption kinetics in the acute postprandial period via blood lipid biochemistry. The study will be conducted as a randomized acute cross-over meal study. Apparently healthy men will be recruited in the study. They will on 4 test days consume the 4 dairy products and blood will be drawn the following 8 hours.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Matrix structure of dairy products results in different postprandial lipid responses: a randomized crossover trial.
Kjølbæk L, Schmidt JM, Rouy E, Jensen KJ, et al · · 2021 · cited 14× · PMID 34477812 · DOI 10.1093/ajcn/nqab220 -
Effect of Dairy Matrix on the Postprandial Blood Metabolome.
Thøgersen R, Egsgaard KL, Kjølbæk L, Jensen KJ, et al · · 2021 · cited 9× · PMID 34959831 · DOI 10.3390/nu13124280 -
Progression of Postprandial Blood Plasma Phospholipids Following Acute Intake of Different Dairy Matrices: A Randomized Crossover Trial.
Thøgersen R, Lindahl IEI, Khakimov B, Kjølbæk L, et al · · 2021 · cited 3× · PMID 34357348 · DOI 10.3390/metabo11070454
Verify or expand the search:
- PubMed search for NCT03656367
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cheddar cheese
Trials testing the same drug.
- NCT01803633 — Determine How Consumption of Dairy Fat as Cheese Influences Inflammation-Phase 2 · NA · active not recruiting
Other recruiting trials for Lipaemia
Currently open trials in the same condition.
- NCT06951386 — The Impact of Daily Intake of Short-chain Fatty Acids on Cardiometabolic Risk Factors in Individuals at Risk for Metabol · NA · recruiting
Other Anne Birgitte Raben trials
Trials by the same sponsor.
- NCT04226911 — Sweeteners and Sweetness Enhancers: Prolonged Effects on Health, Obesity and Safety · NA · completed
- NCT03512509 — Comparison of Low GI and High GI Potatoes in Relation to Satiety (POSAT) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03656367 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anne Birgitte Raben
- Last refreshed: 1 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03656367.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing